|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Current assets | |||||||||||||||
| Cash | |||||||||||||||
| Prepaid expenses and other assets | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Investments | |||||||||||||||
| Accounts receivable, net of allowance for expected credit loss of $3 and $0 at June 30, 2022 and December 31, 2021, respectively | |||||||||||||||
| Inventories, net | |||||||||||||||
| Insurance receivable | |||||||||||||||
| Prepaid expenses | |||||||||||||||
| Deferred costs | |||||||||||||||
| Prepaid inventories | |||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||
| Total current assets | |||||||||||||||
| Restricted cash equivalents held in Trust Account | |||||||||||||||
| Marketable securities held in Trust Account, at fair value | |||||||||||||||
| Restricted cash | |||||||||||||||
| Property, plant and equipment, net | |||||||||||||||
| Equity method investments | |||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||
| Finance lease right-of-use assets | |||||||||||||||
| Deferred assets | |||||||||||||||
| Prepayment - long-term supply agreement | |||||||||||||||
| Insurance receivable | |||||||||||||||
| Other noncurrent assets | |||||||||||||||
| Total assets | |||||||||||||||
| Liabilities and stockholders’ equity | |||||||||||||||
| Current liabilities | |||||||||||||||
| Accounts payable | |||||||||||||||
| Franchise tax payable | |||||||||||||||
| Income tax payable | |||||||||||||||
| Accrued expenses | |||||||||||||||
| Contract liabilities | |||||||||||||||
| Current maturities of long-term debt | |||||||||||||||
| Current maturities of long-term debt to related parties | |||||||||||||||
| Operating lease liabilities, current | |||||||||||||||
| Finance lease liabilities, current | |||||||||||||||
| Legal settlement payable | |||||||||||||||
| Other current liabilities | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Deferred legal fees | |||||||||||||||
| Deferred underwriting commissions | |||||||||||||||
| Note payable | |||||||||||||||
| Long-term debt, net of current portion | |||||||||||||||
| Public and private placement warrants | |||||||||||||||
| Private placement warrants | |||||||||||||||
| Operating lease liabilities, net of current portion | |||||||||||||||
| Finance lease liabilities, net of current portion | |||||||||||||||
| Legal settlement payable | |||||||||||||||
| Total liabilities | |||||||||||||||
| Class A common stock, $0.0001 par value; 22,073,865 and 22,061,272 shares subject to possible redemption at $10 per share at September 30, 2020 and December 31, 2019 respectively | |||||||||||||||
| Class A common stock | |||||||||||||||
| Total class A common stock, $0.0001 par value; 22,073,865 and 22,061,272 shares subject to possible redemption at $10 per share at September 30, 2020 and December 31, 2019 respectively | |||||||||||||||
| Stockholders’ equity | |||||||||||||||
| Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding at December 31, 2021 and December 31, 2020) | |||||||||||||||
| Notes receivable from stockholders | |||||||||||||||
| Common stock ($0.0001 par value, 250,000,000 shares authorized, 185,811,279 and 134,458,439 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively) | |||||||||||||||
| Class A common stock | |||||||||||||||
| Class B common stock | |||||||||||||||
| Total common stock ($0.0001 par value, 250,000,000 shares authorized, 185,811,279 and 134,458,439 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively) | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Series Seed Preferred Stock | |||||||||||||||
| Class A common stock | |||||||||||||||
| Class B common stock | |||||||||||||||
| Total stockholders’ equity | |||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||
Loading...